Proteins are estimated to lead high-protein infant nutrition ingredients demand with 24.0% share in 2026, followed by plant as set to secure 18.0% share of source demand during 2026. Adoption reflects nutritional quality requirements and infant-specific safety evidence, with lengthy clinical qualification and inconsistent ingredient functionality forming principal barriers.